1. What Is the Clinical Correlation of Cardiac Noradrenergic Denervation in Parkinson Disease?
   Guillaume Lamotte et al, 2021, Neurology CrossRef
2. Evaluation of autonomic functions of patients with multiple system atrophy and Parkinson’s disease by head-up tilt test
   Chikako Watano et al, 2018, Journal of Neural Transmission CrossRef
3. Orthostatic hypotension and cognitive impairment in Parkinson's disease: Causation or association?
   Claire McDonald et al, 2016, Movement Disorders CrossRef
4. Clinical characteristics of patients with Parkinson's disease with reduced 123I-metaiodobenzylguanidine uptake in the major salivary glands and heart
   Junya Ebina et al, 2024, Journal of the Neurological Sciences CrossRef
5. Does fatigue in Parkinson’s disease correlate with autonomic nervous system dysfunction?
   Enrica Olivola et al, 2018, Neurological Sciences CrossRef
6. Does 123I-MIBG scintigraphy really assist the diagnosis of Parkinson's disease?
   Agostino Chiaravalloti et al, 2013, Parkinsonism & Related Disorders CrossRef
7. Assessing autonomic dysfunction with functional imaging in Parkinson's disease
   Jacob Horsager et al, 2021, Autonomic Dysfunction in Parkinson's Disease CrossRef
8. Reduced 123I-MIBG uptake in the parotid and submandibular glands in patients with Parkinson’s disease identified using a quantitative semi-automatic method
   Junya Ebina et al, 2023, Journal of Neurology CrossRef
9. Accuracy and cutoff values of delayed heart to mediastinum ratio with 123I-metaiodobenzylguanidine cardiac scintigraphy for Lewy body disease diagnoses
   Guillaume Lamotte et al, 2015, BMC Neurology CrossRef
10. Role of myocardial 123I-mIBG innervation imaging in the diagnosis of neurodegenerative diseases
    Albert Flotats, 2018, Clinical and Translational Imaging CrossRef
11. Cardiac 123I-Metaiodobenzylguanidine (MIBG) Scintigraphy in Parkinson’s Disease: A Comprehensive Review
    Jamir Pitton Rissardo et al, 2023, Brain Sciences CrossRef
12. Findings of 123I-MIBG Cardiac Scintigraphy: Parkinson’s Disease and Related Disorders and Others (RBD, Cardiac Diseases, DM, etc.)
    Makiko Yogo et al, 2017, Clinical Assessment of the Autonomic Nervous System CrossRef
13. Cardiac sympathetic denervation is not related to nigrostriatal degeneration in Parkinson’s disease
    Agostino Chiaravalloti et al, 2013, Annals of Nuclear Medicine CrossRef
14. DL‑3‑n‑butylphthalide therapy for Parkinson's disease: A randomized controlled trial
    Haiyan Zhou et al, 2019, Experimental and Therapeutic Medicine CrossRef
15. Sensitivity and specificity of cardiac 123I-MIBG scintigraphy for diagnosis of early-phase Parkinson's disease
    Miki Kawazoe et al, 2019, Journal of the Neurological Sciences CrossRef
16. Neuroimaging and fluid biomarkers in Parkinson’s disease in an era of targeted interventions
    Angeliki Zarkali et al, 2024, Nature Communications CrossRef
17. Imaging the Functional Brain-Heart Axis: Neurodegenerative Diseases
    Giorgio Treglia et al, 2015, Autonomic Innervation of the Heart CrossRef
18. Validation of Iodine-131-meta-iodobenzylguanidine cardiac scintigraphy in Parkinsonism: A preliminary study
    Dan Xu et al, 2018, Parkinsonism & Related Disorders CrossRef
19. Cardiac sympathetic denervation and dementia in de novo Parkinson's disease: A 7-year follow-up study
    Mun Hee Choi et al, 2017, Journal of the Neurological Sciences CrossRef
20. 123I-meta-iodobenzylguanidine (MIBG) cardiac scintigraphy in α-synucleinopathies
    Satoshi Orimo et al, 2016, Ageing Research Reviews CrossRef
21. Central Aortic Pressure and Arterial Stiffness in Parkinson’s Disease: A Comparative Study
    Mehmet Balal et al, 2022, Parkinson's Disease CrossRef